Interview with Carlos Apellaniz, Healthcare Partner, Korn/Ferry Mexico
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
Address: Montes Urales 505, 3rd Floor Lomas de Chapultepec Del. Miguel Hidalgo 11000 Mexico DF ,Mexico
Tel: 55 5095 9500
Web: http://https//www.kornferry.com/
Since our inception, clients have trusted Korn/Ferry to help them recruit world-class leadership talent. Building on this heritage, today we are a single source for a wide range of leadership and talent consulting services. From our nearly 80 offices in 40 countries, we assist organizations in attracting, engaging, developing, and retaining their people. Services range from executive recruitment to leadership development programs, enterprise learning, succession planning and recruitment outsourcing.
As one of the world’s top ranked leadership and talent consulting firms, we build more effective people, teams, and organizations to drive accelerated business results, and achieve sustainable change. We work with Boards, CEOs, CHROs, and CLOs to align their talent strategy with their business strategy — bringing together deep consulting expertise with the most advanced research-validated methodologies available. Our goal is to transform the lives of the people and organizations we serve, and the worldwide leadership and talent industry.
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
From the perspective of international pharmaceuticals developers, Latin America can be considered a region of exceptional potential owing to solid market fundamentals and significant untapped opportunities. “I am convinced that…
Diego Ocampo, Vice President of Technology at Neolpharma and President of the Mexican Foundation for Health Innovation (INCIDE), represents a new generation of pharmaceutical leadership combining global perspective with regional…
Carlos Abelleyra leads Medix, a 70-year-old Mexican pharmaceutical company undergoing a major strategic transformation. Since 2024, he has diversified the firm beyond its historical obesity focus, establishing divisions in vitamins,…
Raphaël Chin-Fo-Sieeuw, Vice President Life Sciences and Healthcare Americas, DHL Group outlines the Americas as a core growth region, with strong momentum in Latin America. He details DHL’s multi-billion-Euro investment…
Fernando Zarate, Vice President of Bausch Health’s Latin American operations, outlines the company’s strategic positioning across the region. With 35 years in the industry and nearly two decades at Bausch…
Guy Savoir, CEO at Carnot Laboratorios, brings strategic vision to Mexico’s pharmaceutical reindustrialisation. Leading a company that has achieved balanced growth across Mexican and Latin American markets, he articulates an…
Ricardo Amtmann, President of Sanfer Group, discusses the company’s evolution from a licensing-dependent operation into Latin America’s most vertically integrated pharmaceutical enterprise. With nearly 14,000 employees across the region, Sanfer…
Constanza Losada, VP & General Manager for Latin America at BMS, leads one of the company’s fastest-growing regions, driving access to innovation, regional collaboration, and talent mobility. With major investments…
Adriana Eguia Alaniz is President of Tijuana EDC, leading efforts to diversify and strengthen the region’s economy. Under her leadership, Tijuana has strengthened its role as a major medical device…
Miguel Marti highlights Mexico as the Cardinal Health’s top market in Latin America, representing 25 percent of regional operations. Key priorities include thrombosis prevention, enteral nutrition, and surgical gloves. With…
Sandra Ramirez, Latam Area Lead, Astellas Pharma, outlines the company’s strong momentum across Mexico, Colombia, Argentina, and Chile, highlighting regulatory innovation, strategic partnerships, and expanded patient access. She discusses the…
Arturo De la Rosa, Vice President for Latin America at Gilead Sciences, leverages deep regional experience to navigate healthcare challenges and opportunities across multiple countries. He oversees a dual strategy,…
See our Cookie Privacy Policy Here
